Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

ClinicalTrials.gov ID: NCT00132886

Public ClinicalTrials.gov record NCT00132886. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 6:47 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Single Oral Tolvaptan Tablets on Hemodynamic Parameters in Subjects With Heart Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will look at how a single dose of study medication (tolvaptan) versus an inactive sugar pill (placebo) effect pressures in the heart in patients with congestive heart failure. Higher than normal pressures can be related to symptoms of heart failure (shortness of breath, fatigue, etc.).

Study identification

NCT ID
NCT00132886
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
140 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2004 (Type not available)
Primary completion
Dec 2006 (Actual)
Completion
Dec 2006 (Actual)
Last update posted
May 3, 2012

2004 – 2006

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
Oracle Research, A Div of the Heart Center Huntsville Alabama 35801 —
Merced Heart Associates Merced California 95340 —
Olive View-UCLA Medical Center Sylmar California 91324 —
Broward General Medical Center Fort Lauderdale Florida 33316 —
Cardiovascular Center at Shands Jacksonville Jacksonville Florida 32209 —
Tampa General Hospital Tampa Florida 33606 —
ACRI Atlanta Georgia 30342 —
Northwestern University Chicago Illinois 60612 —
Robert Rush University Medical Center Chicago Illinois 60612 —
Loyola University of Chicago Maywood Illinois 60153 —
University of Iowa Health Care Iowa City Iowa 52242 —
Cardiologist Institute Slidell Louisiana 70458 —
Medical Research Institute Louisiana Heart Hospital Slidell Louisiana 70458 —
Primary Cardiology Associates Ayer Massachusetts 01432 —
U-MASS Memorial Medical Center Worchester Massachusetts 01655 —
Henry Ford Hospital Detroit Michigan 48202 —
Washington University School of Medicine St Louis Missouri 63110 —
Heart Consultants, PC Omaha Nebraska 68122 —
University of Medicine and Dentistry Newark New Jersey 07103 —
UNC Heart Failure Program Chapel Hill North Carolina 27517 —
University of Cincinnati Cincinnati Ohio 45267 —
Cleveland VA Medical Center Cleveland Ohio 44106 —
Oregon Health Sciences University Portland Oregon 97239 —
Guthrie Foundation Syre Pennsylvania 18840 —
Texas Heart Institute Houston Texas 77702 —
Southeast Texas Clinical Research Orange Texas 77702 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00132886, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2012 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00132886 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →